Report
03 Dec 2018
This report aims to provide policymakers and enforcers with a basis for reflection on the positive impacts that protecting consumers bears in promoting more inclusive and sustainable development.
Report
28 Nov 2018
This report sheds some light on the nature of the challenges that agriculture and food systems are facing now and throughout the 21st century, and provides some insights as to what is at stake and what needs to be done.
Report
27 Nov 2018
This publication identifies the local and Europe-wide challenges of implementing diabetes evidence into practice and makes recommendations based on the findings.
Report
27 Nov 2018
This document presents the four priorities identified from a consultation with the Blue Circle Voices (BCV), including access and affordability of medicines, devices and medical care, education, prevention and discrimination. It also calls governements to action to improve them.
Briefs & Fact Sheets
27 Nov 2018
This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).
Fact sheet
27 Nov 2018
This fact sheet describes tobacco use as the one risk factor common to the four main groups of NCDs — cardiovascular disease, cancer, chronic lung disease and diabetes.
Report
27 Nov 2018
This briefing paper highlights the NCD Alliance call for accelerated implementation of the WHO Framework Convention on Tobacco Control (FCTC).
Fact sheet
27 Nov 2018
This sheet offers keys facts on schizophrenia, including information on symptoms and causes. It also highlights treatment and care, as well as the WHO response.
Fact sheet
27 Nov 2018
This sheet offers keys facts on epilepsy, including information on signs and symptoms and causes. It also highlights prevention, as well as the WHO response.
Fact sheet
27 Nov 2018
This sheet offers keys facts on dementia, including information on signs and symptoms, common forms, and rates. It also highlights management, as well as the WHO response.
27 Nov 2018
This app provides non-specialized health-care providers with access to comprehensive information to help them diagnose and treat a range of mental, neurological and substance use (MNS) disorders including depression, epilepsy and dementia from their tablets or mobile phones.
Guide
27 Nov 2018
The mhGAP Evidence Resource Centre contains the background material, process documents, and the evidence profiles and recommendations in electronic format for mhGAP guidelines for mental, neurological, and substance use (MNS) disorders. The evidence resource centre is organized around the mhGAP priority conditions.
